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Human dental pulp stem cells (DPSCs) contain subsets of progenitor/stem cells with high angiogenic,
neurogenic and regenerative potential useful for cell therapy. It is essential to develop a safe and efﬁ-
cacious method to isolate the clinical-grade DPSCs subsets from a small amount of pulp tissue without
using conventional ﬂow cytometry. Thus, a method for isolation of DPSCs subsets based on their
migratory response to optimized concentration of 100 ng/ml of granulocyte-colony stimulating factor (G-
CSF) was determined in this study. The DPSCs mobilized by G-CSF (MDPSCs) were enriched for CD105, C-
X-C chemokine receptor type 4 (CXCR-4) and G-CSF receptor (G-CSFR) positive cells, demonstrating stem
cell properties including high proliferation rate and stability. The absence of abnormalities/aberrations in
karyotype and lack of tumor formation after transplantation in an immunodeﬁcient mouse were
demonstrated. The conditioned medium of MDPSCs exhibited anti-apoptotic activity, enhanced migra-
tion and immunomodulatory properties. Furthermore, transplantation of MDPSCs accelerated vasculo-
genesis in an ischemic hindlimb model and augmented regenerated pulp tissue in an ectopic tooth root
model compared to that of colony-derived DPSCs, indicating higher regenerative potential of MDPSCs. In
conclusion, this isolation method for DPSCs subsets is safe and efﬁcacious, having utility for potential
clinical applications to autologous cell transplantation.
 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY-NC-ND license. 1. Introduction mesenchymal stem cells (MSCs) derived from bone marrow and ad-Dental pulp stem cells have many advantages for clinical appli-
cations in dentin/pulp regeneration compared with othererase chain reaction; G-CSF,
pulp stem cells.
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Ltd. Open access under CC BY-NC-ND licenipose tissue [1]. The dental pulp stem cells are easily isolated from
discarded teeth following extractionwith very lowmorbidity and no
ethical issues. A higher immunosuppressivity of T-cell alloreactivity
hasbeendemonstrated indental pulp stemcells than inbonemarrow
stem cells [2]. Some subfractions of adult dental pulp stem cells, such
as the CD31- side population (SP), have greater migration and higher
expression of many angiogenic/neurotrophic factors than bone
marrowand adipose tissue-derived stem cells of the same individual,
leading to enhanced pulp regeneration [1]. On the other hand, pulp
CD31- SP cells and CD105þ cells have a greater effect on angiogenesis/
vasculogenesis and neurogenesis after transplantation both inmouse
hindlimb ischemia and rat brain ischemia compared with colony-
derived dental pulp stem cells (DPSCs) [3,4]. Regenerated pulpse. 
M. Murakami et al. / Biomaterials 34 (2013) 9036e9047 9037tissue is alsomuchhigher involumeand less likely tomineralize after
autologous transplantation of CD31- SP cells or CD105þ cells into the
pulpectomized root canal in dog teeth compared with DPSCs [4,5].
Thus, certainDPSCs subsetsmightbeuseful forcell-based therapy for
angiogenesis/vasculogenesis and re-innervation/neurogenesis in
ischemic diseases, nerve injury, and pulpitis [3,6e11]. Clinical trials
for regeneration are currently under consideration to harness the
therapeuticpotential of humanDPSCs subsets.However, a remaining
challenge for manufacturing clinical grade human DPSCs subsets is
the requirement for good manufacturing practice (GMP) grade cell
isolation and processing. The safety of these CD31- SP cells and
CD105þ cells isolated by ﬂow cytometer has not been established. On
the other hand, another isolation method using immuno-magnetic
beads of CD34, such as the Isolex 300i Magnetic Cell Selection Sys-
tem device (Baxter) presently used for clinical applications [12,13], is
not suitable for human DPSCs subsets because a limited volume of
pulp tissue or a limited number of the primary pulp cells is available
and CD34 is not a validated cell surface marker for pulp stem cell
isolation. The costs will be prohibitive if CD105-magnetic beads are
speciallymade to order for pulp stem cell isolation. Recently,methods
have been further developed to isolate the MSCs in a closed system,
including the Bone Marrow MSC Separation Device [14] for bone
marrow and the Celution system [15] for adipose tissue. However,
there are nomethodsor systems inplace to isolateDPSCs subsetswith
high regenerative potential for clinical use. Therefore, a cost effective
method for the isolation of DPSCs subsetsmust be developed, leading
to safe and efﬁcacious isolation from small amounts of pulp tissue.
Hematopoieticstem/progenitorcells fromthebonemarrow,suchas
CXCR4þ cells, canbemobilizedby their chemotactic reactivity in a SDF-
1 gradient [16e18]. CXCR4þ dental pulp cells are localized to the peri-
vasculararea [19], a functionalniche for stemcells. The ligandofCXCR4,
SDF-1, induces a strong chemotactic response in DPSCs [1]. CXCR4 is
more highly expressed in fractionated pulp CD105þ stem/progenitor
cells comparedwith colony-derivedDPSCs [5] and is thought to be one
of the stem cell markers. However, SDF-1 induced migration for the
isolation of subsets of DPSCs cannot be used as SDF-1 has not been
approved for clinical use. A potential alternative is granulocyte-colony
stimulating factor (G-CSF) which is already approved by the Food and
DrugAdministration (FDA) for clinical use.Many reports have revealed
thatG-CSFhas the ability tomobilize notonly hematopoietic stemcells
but also MSCs from bone marrow [20,21]. Our preliminary data
revealed that the migration of pulp CD105þ stem/progenitor cells to-
ward G-CSF was signiﬁcantly higher than that of DPSCs.
Thus, we have devised an isolation method for a subset of DPSCs
employing an optimized G-CSF-induced mobilization. The regener-
ative potential of dental pulp stem cells mobilized by G-CSF
(MDPSCs) was compared with DPSCs in an ischemic hindlimb model
and an ectopic tooth root transplantationmodel, and evaluated utility
for potential clinical applications to autologous cell transplantation.
2. Materials and methods
This study was approved by the ethics committees and the animal care and use
committees of the National Center for Geriatrics and Gerontology, Research Institute
and Aichi Gakuin University. All experiments were conducted using the strict
guidelines of the DNA Safety Programs.
2.1. Cell isolation and the culture conditions
Normal human third molars were collected from adults (18e29 years of age,
n¼ 12) at the Aichi Gakuin University Dental Hospital under approved guidelines set
by the School of Dentistry, Aichi Gakuin University and the National Center for
Geriatrics and Gerontology, Research Institute. Dental pulp cells were isolated from
human dental pulp tissue enzymatically with a slight modiﬁcation of a previously
described method [22]. Brieﬂy, dental pulp tissue was minced into pieces and then
enzymatically digested. The number of isolated cells and their viability was deter-
mined by trypan blue staining of the cells. The isolated cells were plated at 3  104
cells on 35 mm dishes (BD Biosciences, Franklin Lakes, NJ) in Dulbecco’s ModiﬁedEagle’s Medium (DMEM) (SigmaeAldrich, St. Louis, MO) supplemented with 10%
human serum collected from healthy consenting adult donors. The colony-derived
dental pulp stem cells (DPSCs) were detached by incubation with TrypLE Select
(Invitrogen, Carlsbad, CA) prior to 70% conﬂuence.
CD105þ cells were isolated from human dental pulp cells as described previ-
ously [23]. A human minicircle (mc)-iPS cell line was purchased from System Bio-
sciences (Mountain View, CA) and cultured in Repro FF2 (ReproCELL, Yokohama,
Japan) supplemented with 5 ng/ml basic ﬁbroblast growth factor (bFGF, PeproTech,
London, UK). For feeder-free culture of iPS cells, the plate was coated with 1 mg/ml
Laminin-5 (ReproCELL) at 4 C overnight. NIH3T3 cells (clone 5611) were purchased
from Japanese Collection of Research Bioresources (JCRB) Cell Bank (Tokyo, Japan).
2.2. Isolation of DPSCs subsets by G-CSF-induced mobilization
We used a method for isolating subsets of DPSCs utilizing G-CSF (NEUTROGIN,
Chugai Pharmaceutical Co., Ltd. Tokyo, Japan)-induced stem cell mobilization
yielding the MDPSCs. Costar Transwell (a permeable support with an 8.0 mm pol-
ycarbonate membrane 6.5 mm Insert, Corning, Lowell, MA), used as the upper
chamber, was inserted into 24-well tissue culture plates, used as the lower chamber.
The membrane was chemically treated using the same method in TORAYLIGHT
NV, a polysulphone membrane artiﬁcial kidney (generic name: hollow-membrane
dialyzer; authorization number: 22200BZX00871000) (Toray Industries, Inc.,
Tokyo, Japan) to prevent cell attachment. Human colony-derived dental pulp stem
cells (DPSCs) (2  104 cells/100 ml DMEM) at the second passage of culture were
added to the upper chambers, and 390 ml of DMEM supplemented with 10% human
serum and G-CSF was added to the lower chambers. After incubation, the medium
was changed with DMEM supplementedwith 10% human serum andwithout G-CSF.
The optimal conditions for isolation of MDPSCs were determined by varying three
parameters: the cell number, the incubation time, and the G-CSF gradient. To deter-
mine the optimal cell number, 2  104, 5  104, and 1 105 cells were seeded into the
upper chamber; the ﬁnal concentration of G-CSF (100 ng/ml) in the lower chamber and
the incubation time (48 h) were ﬁxed. After 48 h of incubation, the cells that had
transmigrated were enumerated. To determine the optimal incubation time, after 12,
24, 48, and 72 h of incubation, the cells that had transmigrated were determined. The
cell numbers (2  104 cells) that were seeded into the upper chamber and the ﬁnal
concentration of G-CSF (100 ng/ml) in the lower chamberwere ﬁxed. To determine the
suitable concentration of G-CSF in the lower chamber, we prepared DMEM supple-
mented with 10% human serum and 0, 10, 100 or 500 ng/ml of G-CSF. The cell number
(2 104 cells) that was seeded into the upper chamber and the incubation time (48 h)
were ﬁxed. After 48 h-incubation, the medium was changed to DMEM supplemented
with 10% human serum without G-CSF. Once the cells reached 60e70% conﬂuency,
they were detached by incubation with TrypLE Select and subcultured. To evaluate
the colony forming efﬁciency of MDPSCs, 5  102 cells/ml of MDPSCs were seeded at
the third cell culture passage on 6 cm dishes in DMEM supplementedwith 10% human
serum. After 4 days of culture, aggregates of 10 cells were scored as colonies.
2.3. Flow cytometric analysis
Dental pulp stem cells mobilized by G-CSF (MDPSCs) (G-CSF gradient 0, 10, 100,
and 500 ng/ml), were characterized at the 6th cell culture passage, in comparison
with pulp CD105þ cells, and colony-derivedDPSCs (DPSCs) were used as positive and
negative controls, respectively. Theywere immunolabeled for 60min at 4 C with an
anti-hamster IgG negative control (Phycoerythrin-Cy7, PE-Cy7) (eBio299Arm)
(eBioscience, San Diego), a rat IgG2b negative control (PE-Cy7) (RTK4530) (Bio-
Legend), a mouse IgG1 negative control (PE) (MCA928PE) (AbD Serotec), a mouse
IgG1negative control (Allophycocyanin [APC]) (MOPC-21) (BioLegend), amouse IgG1
negative control (Alexa Fluor 647) (MCA928A647) (AbD Serotec), a mouse IgG2a
negative control (Fluorescein isothiocyanate [FITC]) (sc-2856) (Santa Cruz), a mouse
IgG2b negative control (PE-Cy5) (MPC-11) (BioLegend), and the antibodies against
CD29 (PE-Cy7) (eBioHMb1-1) (eBioscience), CD31 (PE) (WM59) (BD Biosciences),
CD44 (PE-Cy7) (IM7) (eBioscience), CD73 (APC) (AD2) (BioLegend), CD90 (Alexa Fluor
647) (F15-42-1) (AbD Serotec), CD105 (FITC) (MEM-229) (Abcam, Cambridge, UK),
CD146 (Alexa Fluor 647) (OJ79c) (AbD Serotec), CXCR4 (FITC) (12G5) (R&D Systems,
Inc., Minneapolis), G-CSFR (FITC) (38660) (R&D Systems), CD40 (APC) (5C3) (Bio-
Legend), CD45 (APC) (HI30) (BioLegend), CD80 (FITC) (2D10.4) (eBioscience), CD86
(PE-Cy5) (IT2.2) (eBioscience), MHC class I (HLA-A, B, and C) (PE) (3F10) (Ancell,
Bayport), and MHC class II (HLA-DP, DQ, and DR) (APC) (TDR31.1) (Ancell).
2.4. Induced differentiation
The differentiation of dental pulp stem cells mobilized by G-CSF (MDPSCs) (G-
CSF gradient 0, 10, 100, and 500 ng/ml) into the angiogenic, neurogenic, and
odontogenic/osteogenic lineages, was determined and compared with pulp CD105þ
cells and colony-derived DPSCs as described previously [24].
2.5. Proliferation and migration assays
To determine the proliferative activity in response to human serum, dental pulp
stem cells mobilized by G-CSF (MDPSCs) (G-CSF gradient, 0, 10, 100, and 500 ng/ml)
Table 2
Relative mRNA expression of stem cell markers, angiogenic, and neurotrophic fac-
tors in dental pulp stem cells mobilized by granulocyte-colony stimulating factor (G-
CSF) (MDPSCs) (G-CSF gradient 0, 10, 100, and 500 ng/ml) compared with colony-
derived DPSCs (DPSCs), pulp CD105þ cells and induced pluripotent stem (iPS) cells.
MDPSCs/DPSCs Pulp CD105þ
cells/DPSCs
iPS cells/
DPSCs
G-CSF
0 ng/ml
G-CSF
10 ng/ml
G-CSF
100 ng/ml
G-CSF
500 ng/ml
Oct3/4 1.1 1.3 2.0 1.3 1.6 1.8
Nanog 1.1 1.3 1.9 1.3 2.1 3.8
Sox2 0.7 26.0 27.7 19.6 40.8 5047.0
Rex1 1.7 2.8 3.0 1.5 1.6 4.7
GDF3 0.9 1.7 3.9 2.9 4.4 4.5
LIN28 1.5 1.8 2.1 1.6 3.7 3.8
Stat3 0.7 1.3 1.9 1.2 1.0 2.9
CXCR4 1.5 21.6 35.5 32.2 42.8 426.0
GM-CSF 1.2 42.2 57.7 50.9 52.3 0.3
MMP3 4.5 40.0 64.9 60.5 40.3 undet.
VEGF 0.5 4.0 6.2 5.0 3.7 1.0
BDNF 1.2 2.0 7.5 4.4 3.7 1.4
GDNF 0.8 3.2 4.6 4.0 2.5 undet.
NGF 0.7 1.9 3.1 2.5 1.8 0.3
NT-3 1.0 3.0 4.2 3.8 3.1 0.4
The experiments were repeated three times (3 lots), and one representative
experiment is presented.
Rex1, reduced expression 1; GDF3, growth and differentiation factor 3; Stat3, signal
transducer and activator of transcription 3; CXCR4, chemokine (C-X-C motif) receptor 4;
GM-CSF, granulocyte-monocyte colony-stimulating factor; MMP3, matrix metal-
loproteinase-3; VEGF, vascular endothelial growth factor; BDNF, brain-derived neuro-
trophic factor; GDNF, glial cell derived neurotrophic factor; NGF, nerve growth factor;
NT-3, neurotrophin-3.
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of culture at 1  103 cells per well in a 96-well plate in DMEM (SigmaeAldrich)
supplemented with 10% human serum. Ten microliters of Tetra-color one (Seika-
gaku Kogyo, Co., Ltd, Tokyo, Japan) was added to the 96-well plate, and the cell
numbers were measured using a spectrophotometer at 450 nm absorbance at 2, 12,
24, 36, 48, 60, and 72 h of culture. Wells without cells were served as negative
controls.
To examine the migratory activity of MDPSCs (G-CSF gradient, 0, 10, 100, and
500 ng/ml), colony-derived DPSCs, pulp CD105þ cells, and iPS cells, a horizontal
chemotaxis assay was performed as described previously [5]. The TAXIScan-FL (ECI,
Inc., Kanagawa, Japan) was used to detect the real-time horizontal chemotaxis of
cells.
2.6. Detection of telomerase activity
Telomerase activity was determined with a Quantitative Telomerase detection
kit (Allied Biotech, Inc., Vallejo, CA) according to the manufacturer’s instructions,
which is based on a PCR-designed telomeric repeat ampliﬁcation protocol (TRAP).
Brieﬂy, MDPSCs, pulp CD105þ cells, colony-derived DPSCs, and iPS cells were lysed
in Lysis Buffer. After centrifugation, the protein concentration of supernatant was
measured in each extract using the BCA protein assay kit (Pierce, Rockford, IL).
Telomerase activity was detected by Applied Biosystems 7500 Real-time PCR system
(Applied Biosystems, Foster City, CA) using whole-cell extract containing 0.5 mg of
protein.
2.7. Real-time RT-PCR
Total RNA was extracted with Trizol (Invitrogen) from MDPSCs (G-CSF gradient
0, 10, 100, and 500 ng/ml), pulp CD105þ cells, DPSCs, and iPS cells. First-strand cDNA
syntheses were performed on the total RNA of these cells by reverse transcription
using the ReverTra Ace-a (Toyobo, Tokyo, Japan) after DNase I treatment (Roche
Diagnostics, Pleasanton, CA) at 37 C for 20 min. Real-time RT-PCR was performed at
95 C for 10 s, 65 C for 15 s, and 72 C for 8 s using primers for the stem cell markers,
Oct3/4, Nanog, Sox2, Reduced expression 1 (Rex1), Growth and differentiation factor 3
(GDF3), LIN28, Signal transducer and activator of transcription 3 (Stat3) and CXCR4 that
were labeled with Light Cycler-Fast Start DNA master SYBR Green I (Roche Di-
agnostics) in a Light Cycler (Roche Diagnostics). To examine the mRNA expression of
the angiogenic and neurotrophic factors, real-time RT-PCR ampliﬁcations of the
granulocyte-monocyte colony-stimulating factor (GM-CSF), matrix metalloproteinase
(MMP)-3, vascular endothelial growth factor (VEGF), brain-derived neurotrophic factor
(BDNF), glial cell derived neurotrophic factor (GDNF), nerve growth factor (NGF), neu-
rotrophin-3 (NT-3) were also performed (Supplementary Table 1). The mRNA
expression was normalized with b-actin. The RT-PCR products were subcloned into
the pGEM-T easy vector (Promega, Madison, WI) and conﬁrmed by sequencing.
2.8. Effect of MDPSCs-conditioned medium
At 60% conﬂuency, the culture mediumwas switched to DMEM without serum,
and the conditioned media from MDPSCs (G-CSF gradient 100 ng/ml), pulp CD105þ
cells, and DPSCs were collected 24 h later and concentrated approximately 25-fold
by an Amicon Ultra-15 Centrifugal Filter Unit with an Ultracel-3 membrane (Milli-
pore, Billerica, MA). Protein concentration of the conditionedmediawas determinedTable 1
Flow cytometric analysis of cell surface markers on dental pulp stem cells mobilized by gra
500 ng/ml) compared with colony-derived DPSCs (DPSCs) and pulp CD105þ cells.
MDPSCs (n ¼ 3)
G-CSF 0 ng/ml G-CSF 10 ng/ml G-CSF 100 n
CD29 98.5  0.7 96.9  2.0 97.5  0.6
CD31 0.1  0.1 0.5  0.3 0.0  0.0
CD44 99.2  0.9 98.9  0.9 97.4  2.6
CD73 96.2  4.0 99.0  0.4 97.91.4
CD90 97.5  0.1 98.5  0.8 98.2  1.7
CD105 62.8  6.4 **94.5  0.7 **97.8  0.4
CD146 10.5  2.9 12.1  4.2 12.3  3.1
CXCR4 6.5  2.0 **12.0  1.3 **18.2  2.3
G-CSFR 20.5  4.7 **31.0  2.3 **58.9  6.2
CD40 0.4  0.1 0.0  0.0 0.0  0.0
CD45 0.0  0.0 0.1  0.1 0.0  0.0
CD80 **2.8  0.3 **2.8  0.9 **2.3  0.6
CD86 0.5  0.0 0.9  0.2 0.8  0.3
MHC class I 94.7  1.4 92.6  2.5 97.9  1.3
MHC class II 0.5  0.3 1.6  0.4 0.3  0.2
CXCR4, chemokine (C-X-C motif) receptor 4; G-CSFR, granulocyte-colony stimulating fac
**p < 0.01, *p < 0.05 versus DPSCs.by BradfordUltra (expedeon, Cambridge, UK). Each conditioned media were added
to a ﬁnal concentration of 5 mg/ml.
To assess the proliferative effect of the conditioned medium, NIH3T3 cells were
seeded at 1103 cells per well in a 96-well plate in DMEM (SigmaeAldrich) without
serum supplemented with 5 mg/ml of conditioned medium. Ten microliters of Tetra-
color one (Seikagaku Kogyo, Co., Ltd, Tokyo, Japan) was added to the 96-well plate,
and the cell numbers were measured using a spectrophotometer at 450 nm absor-
bance at 2, 12, 24, 36, 48, 60, and 72 h of culture. Wells without cells were served as
negative controls.
To examine migration activity of NIH3T3 cells in conditioned medium from
MDPSCs (G-CSF gradient 100 ng/ml), pulp CD105þ cells, and DPSCs, a horizontal
chemotaxis assay was performed as described previously [5].
To assess the immunomodulatory effect of the conditioned medium, a mixed
lymphocyte reaction (MLR) assay was performed. Human peripheral blood mono-
nuclear cells (PBMCs) were puriﬁed by a density gradient using heparinized blood
collected from healthy consenting adult donors in a Lymphoprep Tube (Axis-
Shield, Dundee, Scotland). Allogenic PBMCs that were treated with mitomycin Cnulocyte-colony stimulating factor (G-CSF) (MDPSCs) (G-CSF gradient 0, 10, 100, and
Pulp CD105þ
cells (n ¼ 3)
DPSCs (n ¼ 3)
g/ml G-CSF 500 ng/ml
97.8  0.4 97.1  1.5 96.3  1.4
0.5  0.2 0.5  0.1 0.6  0.6
97.4  2.6 97.1  3.0 97.5  1.9
97.8  1.6 98.5  1.4 97.4  1.4
97.3  2.4 97.8  1.8 96.0  3.0
*65.7  1.7 **96.5  0.3 55.6  8.7
27.4  1.7 15.1  2.1 21.7  5.7
**14.2  3.7 *10.1  2.3 5.7  1.0
**35.4  3.9 18.3  0.3 10.6  1.8
0.0  0.0 0.0  0.0 0.3  0.0
0.0  0.0 0.0  0.0 0.0  0.0
**2.0  0.3 **2.3  0.2 7.0  1.3
0.2  0.2 0.3  0.0 0.6  0.2
92.9  2.5 99.3  0.3 95.2  0.2
3.0  0.3 0.2  0.2 1.0  0.4
tor receptor; MHC, major histocompatibility complex.
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humidiﬁed 37 C, 5% CO2 incubator and used as the stimulator in the MLR assay.
Autologous PBMCs and allogenic stimulator PBMCs were co-cultured at 105 cells per
well in a 96-well plate in RPMI-1640 without arginine, leucine, lysine, and phenol
red (SigmaeAldrich) supplemented with 5 mg/ml of conditioned medium. The cell
numbers were measured using Tetra-color one at 2, 12, 24, and 36 h as described
above.
To assess the anti-apoptotic effect of the conditioned medium, NIH3T3 cells
were incubated with 500 nM staurosporine (SigmaeAldrich) in DMEM supple-
mented with 5 mg/ml of conditioned medium from MDPSCs, pulp CD105þ cells, and
DPSCs. As a positive control, G-CSF (100 ng/ml) was added. After 3 h, the NIH3T3
cells were harvested, and the cell suspensions were treatedwith Annexin V-FITC and
propidium iodide (Roche Diagnostics) for 15 min and then analyzed by ﬂow
cytometry.
2.9. Maintenance in characteristics of MDPSCs
To evaluate and characterize the stability of MDPSCs, senescence associated
(SA)-b-gal staining assay, telomeric repeat ampliﬁcation protocol (TRAP), real-time
RT-PCR, and western blot analysis were performed. SA-b-gal staining assay was
performed using Senescence Cells Histochemical Staining Kit (SigmaeAldrich) ac-
cording to the manufacturer’s instructions. TRAP was performed described above.
Real-time RT-PCR were performed using primers for senescence related genes
(Interleukin-1b (IL-1b), p16, Interleukin-6 (IL-6), Interleukin-8 (IL-8), p21, Growth
related oncogene-a (GROa)) (Supplemental Table 1). Western blot analysis were
performed using the anti-p16 antibody (C-20) (1:250) (sc-468, Santa Cruz
Biotechnology Inc, CA), anti-p21 antibody (F-5) (1:500) (Santa Cruz), and anti-b-
actin antibody (RB-9421, NeoMarkers, Fremont, CA). The protein bands were
detected by ImmunoStar Zeta (Wako). The 6th, 12th, 25th, and 30th passages of
culture of MDPSCs and colony-derived DPSCs were compared (n ¼ 3, each).
2.10. Tumorigenicity assay
Human MDPSCs (4  105 cells, 20 ml/site at the 20th passage) were injected into
testis or subcutaneously in 6-week-old NOD/SCID (NOD.CB17-Prkdcscid/J) mice
(JAX Mice stock #: 001303, The Jackson Laboratory, Bar Harbor, Maine) (n ¼ 12
mice) and in 8-week-old KSN nude (KSN/SLC) mice (Japan SLC, Inc., Hamamatsu,
Japan) (n ¼ 15 mice). The mice were sacriﬁced and all organs were dissected under
anesthesia after collecting blood from the post-vena cava for hematological exam-
ination 16 weeks later. Hematological examination was performed by using an
automated hematology analyzer (Siemens Healthcare Diagnostics Manufacturing,
Erlangen, Germany), and morphological analyses of blood cells were performed in
blood smear with Wright’s stain under light microscopy. All organs including testis
were histopathologically examined.
2.11. Q-banding karyotype analysis
To analyze the karyotype of MDPSCs at the 20th passage, chromosomes pre-
pared from cells were stained with quinacrine mustard (SigmaeAldrich) and
Hoechst 33258 (SigmaeAldrich) dissolved in a McIlvane’s buffered solution (pH 7.0)
and examined under a ﬂuorescence microscope. Suitable metaphases were photo-
graphed and karyotypes were analyzed.
2.12. Transplantation into mouse ischemic hindlimbs
The angiogenic potential of MDPSCs, pulp CD105þ cells, DPSCs, and human iPS
cells were examined in a murine model of hindlimb ischemia [25] in 5-week-old
severe combined immunodeﬁcient (SCID) mice (CB17, CLEA, Tokyo) (n ¼ 12 mice,
each) as described previously [24]. Brieﬂy, 24 h after ligation of the left proximal
portion of the femoral artery, 1  106 cells of MDPSCs (G-CSF gradient 100 ng/ml),
pulp CD105þ cells and DPSCs in 50 ml of PBS were injected intramuscularly at the 6-Fig. 1. Multi-lineage differential potential and the characteristics of the dental pulp stem
(AeR) Multi-lineage differential potential of MDPSCs (G-CSF gradient 100 ng/ml) compar
differentiation potential using the matrigel assay. (DeF) Neurosphere formation. Fourtee
Fourteen days after induction of dissociated neurosphere cells. (J) Neuroﬁlament, Neurom
Adipogenic differentiation potential. (N) Peroxisome Proliferator-Activated Receptor g (P
Odontoblast differentiation potential. (R) Osteocalcin mRNA expression. (S) Detection of t
and induced pluripotent stem cells (iPS) by real-time polymerase chain reaction (PCR). **
DPSCs. (U) The proliferation of MDPSCs using various concentrations of G-CSF (10, 100, 50
(V) Migration of MDPSCs using various concentrations of G-CSF, pulp CD105þ cells, DPS
medium (CM) of MDPSCs (G-CSF gradient 100 ng/ml). (W) The proliferation of NIH3T3 ce
(X) The migration of NIH3T3 cells using CM of MDPSCs, pulp CD105þ cells, and DPSCs. **p
of MDPSCs, pulp CD105þ cells, and DPSCs. **p < 0.01, *p < 0.05, versus DPSCs CM. (Z) T
Annexin V staining. ##p < 0.01, **p < 0.01 Data are expressed as the means  SD o
representative experiment is presented.8th passage of culture with DiI (SigmaeAldrich). PBS injectionwithout cells was also
used as a negative control. Laser Doppler imaging (Perimed AB, Stockholm, Sweden)
was performed 14 days after cell transplantation. Isolated muscle tissue of the
ischemic hindlimb was ﬁxed in 4% paraformaldehyde (PFA) (SigmaeAldrich) at 4 C
overnight and then embedded in an optimal cutting temperature (OCT) compound
(Sakura ﬁnetek Japan Co., Ltd., Tokyo, Japan) after being immersed in a 30% sucrose
solution. Fluorescein Griffonia (Bandeiraea) Simplicifolia Lectin 1/ﬂuorescein-gal-
anthus nivalis (snowdrop) lectin (20 mg/ml; Vector Laboratories, Inc., Youngstown,
OH) immunostaining was performed on the cryosections (12 mm thick). Microscopic
digital images of six sections were scanned every 96 mm in a 500 mm  380 mm
rectangular frame on a ﬂuorescence microscope (BIOREVO, model BZ-9000 KEY-
ENCE, Osaka, Japan), and statistical analyses were performed using Dynamic cell
count BZ-HIC (KEYENCE). The co-localization of DiI-labeled transplanted cells and
the newly formed BS-1 lectin-positive capillaries were examined using confocal
laser microscopy (TCS SP5 conventional inverted microscope, Leica Microsystems,
Wetzlar, Germany).
2.13. An experimental model of subcutaneous transplantation of the human tooth
root
A subcutaneous ectopic transplantation model of the human tooth root was
used for evaluation of ectopic pulp regeneration. The human tooth root was cut out,
with dimensions of 6 mm in length and 1 mm in width, followed by enlargement
and sealing of one end with MTA cement. At the 6-8th cell culture passage, 1  106
cells from MDPSCs (G-CSF gradient 100 ng/ml), pulp CD105þ cells, DPSCs, and iPS
cells were injected into the tooth root with collagen TE (Nitta Gelatin, Osaka, Japan),
and each of 4 roots was transplanted subcutaneously into the 5-week-old SCID mice
(CB17, CLEA). The four roots in which only collagen TE was injected were also
transplanted as a control. The roots were harvested for histology after 21 days, ﬁxed
in 4% paraformaldehyde (PFA) (SigmaeAldrich) at 4 C overnight and embedded in
parafﬁn wax (SigmaeAldrich) after demineralization with Kalkitox (Wako, Osaka,
Japan). The parafﬁn sections (5 mm in thickness) were stained with hematoxylin and
eosin (HE). Four sections at 150 mm intervals for 4 roots, each transplanted with four
cell populations, were examined for relative amounts of regenerative tissue, as
described previously [26]. The ratios of the regenerated areas to the root canal areas
were calculated (n ¼ 4 roots). For analysis of matrix formation, each 3 parafﬁn
sections from 4 roots, each transplanted with four cell populations, were also
stained with Masson trichrome (Muto pure chemicals Co., Ltd. Tokyo, Japan). For
neovascularization and innervation analyses, 5-mm-thick parafﬁn sections were
deparafﬁnized and stained with Fluorescein Griffonia (Bandeiraea) Simplicifolia
Lectin 1/ﬂuorescein-galanthus nivalis (snowdrop) (BS-1 lectin) (20 mg/ml) and
PGP9.5 (Ultra Clone Ltd) (1:10,000), respectively [26]. The ratio of the newly formed
BS-1 lectin-positive capillaries to the root canal area was calculated using confocal
laser microscopy (TCS SP5 conventional inverted microscope, Leica Microsystems,
Wetzlar, Germany).
To conﬁrm that the regenerated tissue is functional pulp tissue, western blot
analysis of the expression of thyrotropin-releasing hormone degrading enzyme
(TRH-DE), a pulp tissue biomarker [27] in the regenerated tissue, was performed 21
days after transplantation of MDPSCs (G-CSF gradient 100 ng/ml), pulp CD105þ cells,
and DPSCs (n ¼ 3 roots, each) as described previously [23]. Normal pulp tissue from
the incisors and the peritoneal cavity tissue of the SCID mice were used as positive
and negative controls, respectively. The anti-TRH-DE antibody (N-18) (1:1000) (sc-
83177, Santa Cruz Biotechnology Inc, CA) and anti-b-actin antibody (RB-9421, Neo-
Markers, Fremont, CA) were used. The protein bands were detected by ImmunoStar
Zeta (Wako).
For molecular biological analysis, regenerated tissues were further isolated from
each of the 3 roots 21 days after transplantation of MDPSCs and DPSCs. The normal
pulp tissue from the SCID mice was used as a positive control. Total RNA was iso-
lated, and real-time RT-PCR ampliﬁcations were performed using markers for pulp
tissue, syndecan 3 and TRH-DE [27], a marker for periodontal ligament and pre-
odontoblasts, periostin [28].cells (DPSCs) mobilized by granulocyte-colony stimulating factor (G-CSF) (MDPSCs).
ed with pulp CD105þ cells and colony-derived DPSCs (DPSCs). (AeC) The endothelial
n days after induction, the 6th passage cell populations. (GeI) Neuronal potential.
odulin, and sodium channel, voltage-gated type I a (SCN1A) mRNA expression. (KeM)
PARg) and Adipocyte fatty acid binding protein 2 (aP2) mRNA expression. (OeQ)
elomerase activity of MDPSCs (G-CSF gradient 100 ng/ml), pulp CD105þ cells, DPSCs,
p < 0.01. (T) The cumulative cell number of MDPSCs (G-CSF gradient 100 ng/ml) and
0 ng/ml), pulp CD105þ cells, and DPSCs by 10% human serum. *p < 0.05 versus DPSCs.
Cs, and iPS cells. *p < 0.05, **p < 0.01 versus DPSCs. (WeZ) Effect of conditioned
lls using CM of MDPSCs, pulp CD105þ cells, and DPSCs. **p < 0.01 versus DPSCs CM.
< 0.01, *p < 0.05 versus DPSCs CM. (Y) Mixed lymphocyte reaction (MLR), using CM
he relative percentage of viable and apoptotic cells analyzed by ﬂow cytometry by
f 3 determinations. The experiments were repeated three times (3 lots), and one
M. Murakami et al. / Biomaterials 34 (2013) 9036e9047 90412.14. Statistical analyses
Data are reported as means  SD. P values were calculated using Student’s t test
and Tukey’s multiple comparison test method in SPSS 21.0 (IBM, Armonk, NY).3. Results
3.1. The isolation of dental pulp stem cells by the G-CSF
mobilization
To optimize the isolation methods for DPSCs subsets by the
method of G-CSF-induced stem cell mobilization, the cell numbers
seeded in the upper chamber, the incubation time of the G-CSF-
containing medium and the ﬁnal concentration of G-CSF in the
lower chamber were examined. At ﬁrst, we determined that the
optimal cell number was 2  104 cells/100 ml and that the optimal
incubation timewas 48 h because the number of transmigrated and
attached cells in the lower chamber under these conditions was the
highest (data not shown). When MDPSCs were isolated with these
optimal conditions, the isolation efﬁciency was 5.0%. The MDPSCs
using various concentrations of G-CSF were morphologically
similar, containing stellate cells with long processes and spindle-
shaped cells almost identical to the pulp CD105þ cells isolated by
ﬂow cytometry (Supplementary Fig. 1). The limiting dilution anal-
ysis of the third cell culture passage showed that the frequency of
colony forming units (CFUs) in MDPSCs was signiﬁcantly higher
compared to colony-derived DPSCs (DPSCs) (88.4  7.9%;
80.4  4.1%, respectively, p < 0.05, n ¼ 3).
Next, the optimal concentration of G-CSF was determined based
on an evaluation of “stemness” of MDPSCs using ﬂow cytometric
analysis and real-time RT-PCR analysis. The MDPSCs using various
concentration of G-CSF (0, 10, 100 and 500 ng/ml), pulp CD105þ
cells and DPSCs were positive for CD29, CD44, CD73 and CD90 and
negative for CD31, which are the minimal criteria for MSCs. It is
noteworthy, however, that the percentages of CD105, CXCR4 and G-
CSFR positive cells weremuch higher inMDPSCs using 100 ng/ml of
G-CSF compared with those in other MDPSCs and DPSCs. The per-
centages of CXCR4 and G-CSFR positive cells were also higher in the
MDPSCs using 100 ng/ml of G-CSF than those in pulp CD105þ cells.
These results suggested that the MDPSCs using 100 ng/ml of G-CSF
contained the largest number of pulp stem/progenitor cell pop-
ulations (Table 1). The G-CSF-induced mobilization method for the
isolation of DPSCs subsets was repeated over twenty times,
resulting in highly reproducible technique. Furthermore, the
MDPSCs, pulp CD105þ cells and DPSCs were positive for MHC class I
(HLA-A, B, and C), low positive for CD80, CD86, and MHC class II
(HLA-DP, DQ, and DR), and negative for CD40 and CD45. It was
suggested that little hematopoietic and immunogenic cells were
contained in MDPSCs, pulp CD105þ cells, and DPSCs.
The mRNA expression of the stem cell markers, Oct3/4, Nanog,
Sox2, Rex1, GDF3, LIN28, Stat3 and CXCR4was higher in the MDPSCs
using G-CSF (10, 100, 500 ng/ml) compared to the DPSCs and the
MDPSCs using serum only (without G-CSF) and was similar to that
in pulp CD105þ cells (Table 2). The mRNA expression of the stem
cell markers was the highest in the MDPSCs using 100 ng/ml of G-
CSF compared to the MDPSCs using other concentrations of G-CSF
(Table 2), suggesting that the optimal concentration of G-CSF to
isolate MDPSCs may be 100 ng/ml.
The expression of angiogenic and/or neurotrophic factors, GM-
CSF,MMP3, VEGF, BDNF, GDNF, NGF and NT-3was also the highest in
the MDPSCs using 100 ng/ml of G-CSF compared to the MDPSCs
using other concentrations. The MDPSCs using 100 ng/ml of G-CSF
exhibited much higher expression of these factors compared with
DPSCs (Table 2), implying that MDPSCs have higher angiogenic/
vasculogenic and neurogenic potential. To further characterize thephenotype of MDPSCs, the mRNA expression in MDPSCs (G-CSF
gradient 100 ng/ml) was compared with human iPS cells. The
expression of Sox2 and CXCR4 mRNA was 182 and 12 times higher,
respectively, in iPS cells than in MDPSCs. The MDPSCs, however,
expressed other characteristic stem cell markers, including Oct3/4,
Nanog, Rex1, GDF3, LIN28 and Stat3, almost the same as iPS cells. On
the other hand, the mRNA expression of the angiogenic and/or
neurotrophic factors, GM-CSF, MMP3, VEGF, BDNF, GDNF, NGF and
NT-3 was much higher in MDPSCs compared to iPS cells (Table 2).3.2. The multi-lineage differential potential of MDPSCs
The multi-lineage differential potential of MDPSCs (G-CSF
gradient 100 ng/ml) was compared with that of DPSCs and pulp
CD105þ cells. The MDPSCs (G-CSF gradient 100 ng/ml) formed
extensive networks of cords and tube-like structures after only 6 h
on the matrigel, as did pulp CD105þ cells. However, no such for-
mation was detected in DPSCs (Fig. 1AeC). Fourteen days after
neurogenic induction, clusters of proliferating neurospheres were
more prevalent in MDPSCs (G-CSF gradient 100 ng/ml) and pulp
CD105þ cells compared with DPSCs (Fig. 1DeF). Following further
neuronal induction, neurite outgrowth and the expression of
neuroﬁlament found in MDPSCs were similar to those in pulp
CD105þ cells (Fig. 1GeI). Neuronal markers, such as neuroﬁlament,
neuromodulin, and sodium channel, voltage-gated type 1a (Scn1A),
showed higher mRNA expression in MDPSCs using 100 ng/ml of G-
CSF when compared with the other MDPSCs and DPSCs (Fig. 1J). As
for adipogenic induction, the MDPSCs (G-CSF gradient 100 ng/ml)
and pulp CD105þ cells but also DPSCs were positively stained by
oil red O (Fig. 1KeM), showing expression of the adipogenic
markers, aP2 and PPARgmRNA. The MDPSCs using 100 ng/ml of G-
CSF, however, had the highest adipogenic potential (Fig. 1N).
Finally, 28 days after osteogenic induction, the mineralized matrix
was stained by alizarin red (Fig. 1OeQ), and the osteoblastic
marker, osteocalcin was similarly expressed in all cell populations
(Fig. 1R).3.3. The biological characteristics of MDPSCs
Telomerase activity was 3.7 times and 4.1 times higher in
MDPSCs at the 7th cell culture passage compared with DPSCs and
pulp CD105þ cells, respectively, and 0.6 times higher compared
with iPS cells (Fig. 1S). The cumulative cell number of MDPSCs was
much higher, and the proliferative life span of MDPSCs was longer
than that of DPSCs (Fig. 1T). Proliferation with human serum was
higher in MDPSCs than in DPSCs, but there were no signiﬁcant
differences among the MDPSCs using 10, 100, 500 ng/ml G-CSF
concentrations (Fig. 1U). The G-CSF-induced migratory activity
was much higher in MDPSCs than that in the DPSCs, and the
MDPSCs using 100 ng/ml of the G-CSF exhibited the highest ac-
tivity (Fig. 1V).
The conditioned medium (CM) of the MDPSCs (G-CSF gradient
100 ng/ml) was signiﬁcantly more effective on the proliferation
(Fig. 1W) and migratory activity in NIH3T3 cells (Fig. 1X) compared
with the CM of pulp CD105þ cells and DPSCs. The MLR assay
showed signiﬁcantly enhanced immunosuppression by the CM of
MDPSCs (G-CSF gradient 100 ng/ml) compared with the CM of
DPSCs (Fig. 1Y). The survival rate of NIH3T3 cells was also signiﬁ-
cantly more enhanced by the CM of the MDPSCs (G-CSF gradient
100 ng/ml) compared with the CM of DPSCs (Fig. 1Z). These results
suggested that the MDPSCs using 100 ng/ml of G-CSF exhibited the
biological properties with themost powerful regenerative potential
among the MDPSCs using various concentrations. We therefore
determined the optimal concentration of G-CSF to be 100 ng/ml.
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MDPSCs
To examine the stability of MDPSCs after prolonged ex vivo
culture, expression of cellular senescence markers in the MDPSCs
was compared to that in the DPSCs at the 6th, the 12th, and the
30th passages. Both MDPSCs and DPSCs at the 6th passage and
MDPSCs at the 12th passage were not stained for SA-b-gal, but 3.1%
of DPSCs at the 12th passage was positively stained. At the 30th
passage, the SA-b-gal positive cells were detected in 60% of DPSCs,
but only in 13% of MDPSCs (Fig. 2AeC). The telomerase activity was
decreased in DPSCs at the 25th passage, but showed almost the
same level in MDPSCs at the 25th passage as that in MDPSCs at theFig. 2. Maintenance of the stem cell properties, tumorigenicity assay, and Q-band karyotyp
Senescent associated (SA)-b-gal staining. (C) Percentage of SA-b-gal-positive cells at the 6th,
and DPSCs at the 6th, the 25th and the 30th passages. **p < 0.01. (E) Relative mRNA expressi
Data are expressed as the means  SD of 3 determinations. (F) Protein level of p16 and p21
tumorigenicity in the testis 16 weeks after transplantation of MDPSCs was observed. (H)
experiment was repeated three times (3 lots) and one representative experiment was pres6th passage (Fig. 2D). The mRNA expression of IL-1b, p16, IL-6, and
IL-8 was highly up-regulated in the DPSCs at the 30th passage, but
not in the MDPSCs (Fig. 2E). Western blot analysis revealed that
expression of p16, and p21 was signiﬁcantly increased in DPSCs at
the 25th passage compared to those at the 6th passage, but almost
the same level in MDPSCs between the 6th and the 25th passages
(Fig. 2F). These results indicated the stability of MDPSCs in long-
term in vitro expansion.
Furthermore, intratesticular or subcutaneous injection of
MDPSCs in immunodeﬁcient SCID mice resulted in no teratoma
formation (Fig. 2G) and hematological abnormality. Therewere also
no chromosomal abnormalities/aberrations in the karyotype of
MDPSCs at the 20th passage (Fig. 2H).e analysis of DPSCs mobilized by G-CSF (MDPSCs) (G-CSF gradient 100 ng/ml). (A, B)
the 12th, and the 30th passages. **p < 0.01. (D) Relative telomerase activity in MDPSCs
on of senescence related genes in MDPSCs and DPSCs at the 6th and the 30th passages.
in MDPSCs and DPSCs at the 6th and the 25th passages. (G) Tumorigenicity assay. No
Q-banding analysis for MDPSCs at the 20th passage showing normal karyotype. The
ented.
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transplantation
Fourteen days after transplantation, quantitative analyses of
blood ﬂow and capillary density were performed. Laser DopplerFig. 3. Neovascularization in the ischemic hindlimb 14 days after transplantation of denta
(MDPSCs), pulp CD105þ cells, colony-derived DPSCs (DPSCs), and induced pluripotent stem
Quantiﬁcation of blood ﬂow in the ischemic versus normal limbs obtained from four mice
Simplicifolia Lectin 1/ﬂuorescein-galanthus nivalis (snowdrop) lectin (BS-1 lectin) in the isch
ischemic region using serial sections. Data are expressed as means  SD of 4 determination
representative experiment is presented. (MeP) Localization of DiI-labeled transplanted cellimaging revealed that blood ﬂow was signiﬁcantly increased
approximately 1.8, 2.0 and 2.2 times more in the MDPSCs trans-
plantation compared with DPSCs, iPS cells, PBS control without
cells, respectively (Fig. 3AeF). The capillary density in the ischemic
region transplanted with MDPSCs increased 1.7, 4.3 and 7.4 timesl pulp stem cells (DPSCs) mobilized by granulocyte-colony stimulating factor (G-CSF)
cells (iPS cells). (AeE) Laser Doppler imaging. Accelerated blood ﬂow (arrows). (F)
in each group. *p < 0.05. (GeK) Immunostaining of Fluorescein Griffonia (Bandeiraea)
emic hindlimb. (L) Quantiﬁcation and statistical analysis of the capillary density in the
s. *p < 0.05, **p < 0.01. The experiments were repeated three times (3 lots), and one
s and newly formed capillaries stained by BS-1 lectin.
Fig. 4. Regeneration of pulp tissue after ectopic tooth transplantation in severe combined immunodeﬁciency (SCID) mice. Dental pulp stem cells (DPSCs) mobilized by granulocyte-
colony stimulating factor (G-CSF) (MDPSCs), pulp CD105þ cells, colony-derived DPSCs (DPSCs), and induced pluripotent stem cells (iPS cells) were injected into the emptied root
canals. (AeD) Hematoxylin and Eosin (HE) staining. (EeH) Masson trichrome staining. (IeL) Immunostaining with BS-1 lectin. (M) Ratio of the regenerated area to the root canal
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(Fig. 3GeL). There was no signiﬁcant difference in blood ﬂow or
capillary density between MDPSCs and pulp CD105þ cells. DiI-
labeled MDPSCs, pulp CD105þ cells, and DPSCs were not co-
localized with BS-1 lectin stained blood vessels (Fig. 3MeO),
implying their trophic effect on neovascularization. On the other
hand, iPS cells were co-localized (Fig. 3P), indicating their differ-
entiation potential into endothelial cells.
3.6. Ectopic pulp regeneration in the tooth root after MDPSCs
transplantation
We next evaluated the pulp regeneration potential of human
MDPSCs in an experimental model of ectopic tooth root trans-
plantation in SCID mice. Pulp-like tissue with a well-organized
vasculature was regenerated in the tooth root 21 days after trans-
plantation of MDPSCs, pulp CD105þ cells, DPSCs and iPS cells
(Fig. 4AeD). Masson trichrome staining, however, revealed that
ﬁbrous matrix formation was observed in part of the DPSCs and iPS
cells transplantation (Fig. 4G, H). Statistical analysis showed that
the regenerated area was signiﬁcantly larger (1.2-fold and 1.5-fold,
respectively) in the MDPSCs transplantation compared to the
DPSCs and the iPS cells transplantations, and was similar to the
CD105þ cells transplantation (Fig. 4M). Immunoﬂuorescent stain-
ing analysis with BS-1 lectin demonstrated neovascularization in
the regenerated pulp tissue after all the cell transplantions (Fig. 4Ie
L) but little neuronal process stained with PGP9.5 antibody (data
not shown). Statistical analysis showed that the vascularization
areas were signiﬁcantly larger (1.3-fold, 2.3-fold, respectively) in
the transplantation of MDPSCs compared to DPSCs and iPS cells,
and was similar to that of pulp CD105þ cells (Fig. 4N).
The regenerated tissue was further analyzed by western blot
analysis and real-time RT-PCR analysis. The protein expression of
TRH-DE, a biomarker of pulp tissue, was signiﬁcantly higher in the
regenerated tissue of the MDPSCs transplantation than in those of
the DPSCs transplantation and the pulp CD105þ cells trans-
plantation. There was no signal in the peritoneal cavity tissue
(Fig. 4O). The expression of Syndecan 3 and TRH-DE was similar
between the regenerated tissue of the MDPSCs transplantation and
normal mouse pulp tissue (Fig. 4P). The expression of Periostinwas
higher in the regenerated pulp tissue of the DPSCs transplantation
compared to that of the MDPSCs transplantation (Fig. 4P).
4. Discussion
DPSCs subsets have a higher migration activity compared with
unfractionated pulp cells [5,23]. The mobilization of bone marrow
hematopoietic stem cells in vitro by G-CSF has been previously
reported [29,30]. Thus, in this study, for the ﬁrst time we have
developed a safe and efﬁcacious method to isolate DPSCs subsets
based on G-CSF-induced stem cell mobilization. A special device
was developed in which the transmembrane of the upper chamber
was chemically treated to prevent cell attachment and increase the
number of transmigrating cells. The optimal isolation conditions for
MDPSCs were determined as follows: the plating cell number in the
upper chamber, 2  104 cells/100 ml, the ﬁnal concentration of G-
CSF in the lower chamber, 100 ng/ml, and the incubation time with
G-CSF, 48 h. For the migration of bone marrow hematopoietic stemarea. Data are expressed as means  SD of four determinations. *p < 0.05, **p < 0.01. (N) Rati
of four determinations. *p < 0.05, **p < 0.01. (O) Protein expression of thyrotropin-releasing
of MDPSCs, DPSCs, pulp CD105þ cells, iPS cells, and peritoneal cavity tissue as a negative c
periodontal ligament and preodontoblasts marker, periostin in the regenerated tissue aft
**p < 0.01. The experiments were repeated three times (3 lots), and one representative expcells, 100 ng/ml of G-CSF was added for only 80 min [29]. In our
system, however, the migrating cell number was very low at 12 h
and gradually increased to a maximum at 48 h. The MDPSCs
increased proliferation but did not differentiate into odontoblasts
by exposure to 100 ng/ml of G-CSF (data not shown), suggesting
optimal conditions. The material used for chemically modiﬁcation
of the transmembrane has been already approved for clinical use in
the Japanese Pharmaceutical affairs law with safety conﬁrmation.
Thus, these ﬁndings indicated that MDPSCs can be isolated efﬁ-
ciently and safely from a small number of cells using this device
under the optimal conditions.
Pulp CD105þ cells isolated by ﬂow cytometry are more enriched
for stem/progenitor cells, having a higher angiogenic and neuro-
genic potential, compared with DPSCs [3,5]. Thus, MDPSCs were
compared with DPSCs, pulp CD105þ cells and iPS cells for cell
phenotype, biological characteristics, and regenerative potential in
an ischemic hindlimb model and an ectopic tooth root model. The
cell surface marker expression of CD105, and the mRNA expression
of stem cell markers such as Oct3/4 and Nanog in MDPSCs were
similar to those in pulp CD105þ cells, suggesting a stemness
phenotype of MDPSCs similar to that of pulp CD105þ cells. MDPSCs
exhibited a higher migratory activity and higher expression of
angiogenic/neurotrophic factors in vitro and greater angiogenic/
vasculogenic and regenerative potential in the two in vivo models
compared to DPSCs and iPS cells. The transplanted MDPSCs were
localized in the vicinity of newly formed vessels and not differen-
tiated directly into endothelial cells as the transplanted pulp
CD105þ cells and DPSCs. On the other hand, the transplanted iPS
cells differentiated into endothelials cells in the ischemic hindlimb
model. A similar report has been reported in mouse ischemic brain
model that transplantation of iPS cells can provide neural cells and
vascular endothelial cells and is associated with teratoma forma-
tion [31]. Vascular progenitor cells derived from iPS cells also suc-
cessfully recover blood ﬂow after transplantation in the same
model. The possibility of the contamination of undifferentiated iPS
cells and safety concern for isolation of the differentiated vascular
progenitor cells from undifferentiated iPS cells by ﬂow cytometer,
however, need to be overcome [32]. On the other hand, the absence
of abnormalities/aberrations in karyotype and no tumorigenicity of
MDPSCs in an immunodeﬁcient mouse at the 20th passage of cul-
ture were also demonstrated. Furthermore, G-CSFR and CXCR4 are
more highly expressed in MDPSCs compared to DPSCs, which have
the advantage of a synergistic/additive effect with G-CSF [33] and
SDF-1 [5]. After injection, MDPSCs may be mobilized and home to
the injured sites of the body releasing G-CSF [20,21,34] and/or SDF-
1 [35,36]. Thus, these ﬁndings on safety and efﬁcacy suggest that
MDPSCs are a superior cell source compared to DPSCs and iPS cells
for stem cell therapy. In addition, the MDPSCs can undergo 30 to 40
passages, whereas the adult bone marrow MSCs can grow identi-
cally for 6-10 passages [37]. MDPSCs have demonstrated the sta-
bility of the cell phenotype after long-term expansion including
fewer staining with SA-b-gal, lower expression of mRNA and pro-
teins of senescence markers, p16 and p21 etc. and higher telome-
rase activity compared with DPSCs. These results assume large-
scale produced MDPSCs as “cell medicine” for safety evaluation
and clinical application. Therefore, G-CSF-induced mobilization
might be an efﬁcient and safety method to establish standardized
manufacture guideline for the isolation of MSCs to enrich a subseto of the vascularization area to the regenerated area. Data are expressed as means  SD
hormone degrading enzyme (TRH-DE) in regenerated pulp tissue after transplantation
ontrol. (P) Relative mRNA expression of pulp markers, Syndecan 3 and TRH-DE, and a
er cell transplantation. Data are expressed as means  SD of three determinations.
eriment is presented.
M. Murakami et al. / Biomaterials 34 (2013) 9036e90479046of DPSCs secreting high levels of trophic factors and endowed with
high regenerative potential. The cell banking of MDPSCs for autol-
ogous transplantation will be served with a guarantee of high
quality control.
Expression of the characteristic stem cell markers Sox2, Oct3/4,
Nanog, Rex1, GDF3 and CXCR4 was higher in MDPSCs compared to
DPSCs. Interestingly, Oct3/4, Nanog, Rex1, and GDF3 were similarly
expressed in MDPSCs and iPS cells. iPS cells are generated from
pulp stromal cells [38,39], and the efﬁciency of iPS generation is
higher than that from dermal ﬁbroblasts [39]. Thus, MDPSCs might
be a preferable alternative cell source for the generation of iPS cells
with the potential for higher efﬁciency due to the higher expression
of Sox2 and Oct3/4 compared with DPSCs.
5. Conclusions
An isolation of DPSCs subsets based on their migratory response
to 100 ng/ml of G-CSF is safe and efﬁcacious method. CD105, CXCR-
4 and G-CSFR positive stem cells are enriched in MDPSCs having
high proliferative and migration activities, and trophic effect
including anti-apoptosis, accelerating migration and immunomo-
dulation. MDPSCs are useful cell source for cell therapy not only in
regenerative endodontics but also in other regenerative medicine
applications for ischemic diseases and neuronal injury with higher
regenerative potential compared with DPSCs. MDPSCs isolated
using reagents compatible with good manufacturing practice
(GMP) may be of utility for potential clinical applications in the
near future.
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